Apollo Global Management, Inc. (APO) Earnings Call Transcript & Summary
September 14, 2020
Earnings Call Speaker Segments
Jeremy Campbell
analystAll right, everybody. Good afternoon. We're going to keep the party rolling here. I am Jeremy Campbell, covering the exchanges, brokers and asset manager sector here at Barclays. Joining me from Apollo today are Scott Kleinman, Co-President; and Martin Kelly, CFO and Co-COO. Scott and Martin, thank you for being here at the virtual rendition of the Barclays Global Financial Services Conference with us.
Martin Kelly
executivePleasure.
Jeremy Campbell
analystSo before we hop into Q&A, for those participating via Zoom, we do have audience response questions queued up there. You should be able to see them on the left-hand toolbar. So I think they're all available to you whenever you want to access them. And the first one, I think, will be the most important for Martin and Scott to be kind of interested in getting your read on. So it's how are you positioned in Apollo stock. Are you overweight, equal weight, underweight or not involved? So we'll let you guys kind of queue in there while we kind of get started on the Q&A side of things.
Jeremy Campbell
analystSo I wanted to start here with you guys today on talking about insurance, which is top of mind, I think, for everybody as they're looking at Apollo, right? And we've written quite a bit about the benefits of insurance companies partnering with alt managers. And given the size and the length of your relationship with Athene, I think a lot of people look at that as a blueprint of sorts in getting into those markets. So Scott, I think since you're going to be taking an even more active role in insurance during Marc's sabbatical, I'd just like to get your perspective on the future of insurance for Apollo or the industry. And maybe to kick off there, for a little bit of background for maybe those that aren't as familiar with Apollo and the insurance story, how this relationship with Athene came to be and why you structured it the way you did.
Scott Kleinman
executiveSure, sure. And this is, as you said, it's a bit of ancient history at this point. But really coming out of the GFC, we at Apollo started to notice that there were a handful of insurance companies, particularly in the fixed annuity business, that were undercapitalized, really needed some capital. And so we started recapitalizing a few of these smaller companies, and then about a year later, a very large situation arose with the same circumstances. And that really became the corpus of what was Athene. We had brought in an incredibly talented management team led by Jim Belardi. And on the basis of that, we created, like I said, what is Athene today. But it really wasn't the GFC that propelled Athene to what it is. It really was what came next, right, which is really all about 0% interest rates. And fixed annuities require an insurer to promise a certain rate of return to a policyholder and then be able to earn a spread above that return. And with 0% interest rates, it has become harder and harder for traditional insurers to earn that sort of attractive rate of return. Fortunately, given the Athene relationship with Apollo, Apollo's business is finding interesting rates, interesting credit products or originating interesting credit products at varying risk and return scenarios. And so that's really been the real driver. Athene has really become this solutions provider for the insurance industry.
Jeremy Campbell
analystGot it. And then, Scott, I guess you talked a little bit about the 0 rate coming out of the GFC and guess what, we're back there again. So maybe in that kind of vein, what's your kind of take on the global landscape for insurance opportunities these days?
Scott Kleinman
executiveYes. No, I think it's enormous. Like I was saying, Athene has really now proven through multiple transactions its ability to really solve the specific problems or issues that a particular insurer's trying to deal with. And so the -- this is -- with 0% interest rates, this isn't going away. This is, in fact, only continuing to become a real drag for lots of insurers to continue to clear these type of liabilities off their balance sheets. And so for Athene, this is a really great opportunity. It's a really interesting time in the insurance space right now. And the market is enormous. We have...
Jeremy Campbell
analystYes...
Scott Kleinman
executiveNo, go ahead. I'm sorry.
Jeremy Campbell
analystNo, go ahead.
Scott Kleinman
executiveOh. I was going to say the market is enormous, right? The life market is a $5 trillion market. Pension, risk transfer market is a $3 trillion market. The variable annuity market is a $2 trillion market. So these are enormous, highly fragmented industries that there's plenty of runway, plenty of room for Athene to really keep doing what it's been doing for many, many years to come.
Jeremy Campbell
analystYes. And you've just highlighted the great like TAM that exists here, but it's also been a pretty kind of a competitive dynamic going on here with -- but with now many of your alt brethren that are going to be presenting or have presented here with us these past couple of days having an insurance partner in some form or another. So maybe you could just comment a little bit about like kind of the competitive dynamics in the insurance market these days as it pertains to alternative deal flow and where you think Apollo and Athene, kind of that partnership, sits in that dynamic?
Scott Kleinman
executiveYes. No, look, it's -- I guess imitation is the greatest form of flattery. But no, it's a -- like I said, it's a huge market. There -- while insurance is not a complicated business to understand, in execution, it's actually a very complicated business to run because it's a highly regulated industry. And there's a lot of growing pains, a lot of ways of operating, ways of doing things that aren't necessarily intuitive, but you have to learn really on the job. And we and Athene have had over 10 years of experience really getting up that learning curve. And so not to say others won't figure it out, but it is a long road and -- to really hit the type of scale we've created and then be able to do it at the pace we're now doing it. It's more difficult, more complicated than it looks. But ultimately, I come back to it's a really big market. There's certainly -- it's a big pool, lots of room for multiple people to be swimming. The other thing I'd add is, aside from the insurance, right, it's really the marriage of the insurance and the asset management. Buying liabilities off of a traditional insurance company only to face the same asset issues that they face is really not creating value. And so you also need the credit machine to really be able to generate those attractive assets to line up against those liabilities. And if you don't have that in scale, it also becomes -- it's very difficult to just really get in and scale up. That's also a long investment and build-out process.
Jeremy Campbell
analystGot it. And then maybe I'll just invert it a little bit here. I think if we think about the -- of ourselves now sitting in the seat of like an insurance CEO, right, I think you've laid out a great cadence and argument as to why you should sell. With the lower rate environment, it's hard to make money. But I guess as we think about like the major impediments to your deal flow from an insurance company's angle, what would prevent an insurance company from selling at this point in time where rates are 0 and probably expected to stay 0 for quite some time?
Scott Kleinman
executiveYes. Look, ultimately, every situation is different, comes down to the facts and circumstances at that particular insurer and how those liabilities are held, what type of capital is against it. And so there's really no impediment. You don't have a big origination platform embedded in that insurance company. This is a drag on your overall business. And as a CEO, you would rather be able to redeploy that capital into other things where you can make more money and sell it to an owner that can do more with that business. And really, Athene has become that platform, that solutions provider to be able to do that. So it's not that there's no impediments. It's just -- it's going to be a very facts- and circumstances-driven discussion.
Jeremy Campbell
analystAnd you guys also, in addition to having kind of the Athene relationship here in the U.S., you have Athora, which is kind of almost the Athene of Europe, if you will, to some extent. But as we kind of think about the dynamics between in the U.S. and the European kind of insurance market, what are guys -- what are the puts and takes? How would you characterize the opportunities or the differences for your insurance partners?
Scott Kleinman
executiveYes. Look, I mean, I think, in many ways, the fundamentals are similar. But what I would say in Europe, you have even more years to go, even more fragmentation, more complexity, right? Europe is not one country the way the U.S. is. It is a collection of countries with similar but not exactly the same rules and regulations around insurance. And every country is governed by their own regulator. And those nuances make it trickier to just come in and scale in a big way. And so you have to really build out businesses country by country, business by business. And so again, it just really favors the head start that we have. There is massive optimization and sale and consolidation to happen in Europe, but it is meaningfully more complex than, say, even in the U.S., and -- which is not a bad thing. It just -- to some extent, it's interesting -- it creates interesting barriers, but it just takes a lot of work, a lot of effort, a lot of manpower to really make that happen.
Jeremy Campbell
analystGreat. And then I just want to touch a little bit with some of the management changes in the insurance segment. Obviously, Marc Rowan has kind of taken a bit of a step back from day-to-day operations. But I guess from here, Scott, how does your role within kind of insurance operation change? How do you step up? And where do we think really the growth trajectory for -- opportunity for more growth for Apollo is in the insurance business from here?
Scott Kleinman
executiveSure. Well, look, just to sort of make sure it's very clear, Marc's not disappearing on his sabbatical. He still remains on the Board of Athene, Athora and Apollo. I speak to him fairly regularly, just bouncing strategic thoughts off of him. So he is thankfully still around and available. But no, Apollo has a deep team of folks who have been and continue to be focused on our insurance activities, right? Today, outside of the insurance companies themselves, Athene, Athora, within Apollo, Apollo has over 400 people who spend some or all of their time on our insurance activity. So it has become a very meaningful part of what we do and how we oversee and interact with these affiliated insurance companies. So for me -- look, Marc asked me a couple of years ago to start spending more time with our insurance business. So I've been doing that. So thankfully, when this transition came to pass earlier this year, I was reasonably up to speed on our businesses and what really needed to be done and where we were taking the businesses. So to answer your ultimate question there, I don't really see a fundamental shift. What we've done is working. There's more opportunity where -- to continue what we've been doing. And so certainly for the foreseeable future, it's going to be continued: Drive Athene and Athora to be just fantastic insurance companies. Drive Apollo's credit platform to continue to scale up to meet the demands of those companies and see where -- how we can be the solutions provider to the industry.
Jeremy Campbell
analystYes. And I'd just like to kind of put a cap on that one. Right now, I think, pro forma for Jackson and that deal, I mean you guys were sitting on like $225 billion of insurance assets. You have obviously ample dry powder to do more deals. You characterize the deal flow as pretty attractive right now. Kind of if we look forward here -- and maybe, Martin, you can chime in too. But if we look forward to the end of 2021, is there a level of assets that you'd feel either satisfied or disappointed in?
Scott Kleinman
executiveI'll chime in and then, Martin, you can chime if you like. The answer is I think if there wasn't further transactions before the end of 2021, I'd personally be disappointed just given what I see as the opportunity set. But I don't think I'd want to put a specific number out there for you. I don't know, Martin.
Martin Kelly
executiveYes. Look, Athene has about $7 billion of equity buying power, and that translates to about $80 billion of purchasing power. But strategic growth is M&A. M&A is complicated. It's situational. So it's very hard to handicap, but we're -- we continue to look at opportunities. And just this year between Athene and Athora, we've put $45 billion on VIVAT and close to $30 billion at Jackson. So it's been a tremendously successful year in terms of strategic growth on top of the organic growth at Athene. And so yes, we continue to look at opportunities. It's pretty active on both sides.
Jeremy Campbell
analystYou guys realize I just had to ask the question. It's the one that everybody wants the answer to, right? I guess maybe in a little bit of a different vein, for those that are tuning in that don't quite know you guys, especially with the Athene relationship and Athora as well, you earn kind of a flat fee, and then you have sub-advisory fees that go a little bit higher depending on how esoteric the asset class gets. I guess with yields where they are today -- I mean even just in the U.S. rate curve, we're at like all-time lows, right? Is there any appetite, ability or willingness to kind of shift some of these sub allocations out a little bit further on the curve or risk spectrum to get more spread income for the insurer and then, obviously, for you as managers, potentially kind of remix to some extent on the fee rate?
Scott Kleinman
executiveYes. Look, I mean, ultimately, our insurance companies with our help and input have very complex strategic asset allocations that are built up to really match and optimize the liability profile that they have. It's our job, based on that, to find the best level of return for each unit of risk that, that balance sheet is prepared to take. Risk is one of those things where people use it broadly, but there's a lot of categories of risk. And things like liquidity duration, complexity, these are all things that Apollo understands and manages incredibly well and is always looking to optimize and trade return because we have the ability to assume liquidity, duration and complexity risk. Credit risk, on the other hand, is something that we're not necessarily looking to take more of in order to get more return unless the SAA sort of calls for it. And so that's really the way to think of it, and we've got -- our whole sort of credit machine is built to really think about it that way for our affiliated balance sheets.
Jeremy Campbell
analystGot it. And then just circling back to our audience response question, a little less than 10%, about 7% were overweight stock. About 20% are equal weight. Only about 7% underweight, and the vast -- 2/3 majority here are kind of not involved. So kind of you have an opportunity set in front of you right now. So kind of with that in mind, let's kind of shift to the firm as a whole. And Apollo's organic fee-paying asset growth has been very strong in recent quarters. I think you guys just did over $16 billion of fundraising in ex insurance in the second quarter, which is kind of well underway to your $20 billion fundraising target that you set last quarter. I guess thinking through some of the funds you're currently in the market for, where should we expect to see most of the near-term inflows coming from?
Scott Kleinman
executiveYes. Look, we do have quite a number of products in the market right now. So we're out raising our next Hybrid Value fund. The first fund has gone quite well. And I don't think I'm allowed to give you an exact number just under the fundraising rules, but it will be meaningfully larger than the last one. We're out with an infrastructure fund right now. We are -- we've announced the -- our direct origination platform, ASOP. That also is raising some dedicated funds against it as well. And so those are all in the market right now. So plus -- that plus our evergreen products that we have in the market will probably be what you're seeing in Q3 and Q4 as the big needle movers.
Jeremy Campbell
analystAnd then let's just spend a minute on ASOP too now that you brought it up. I mean, can you just give us a little bit of background on it and how it came about? Is this something that is kind of generated from the LP level? Or did you guys sit your boardroom and kind of said, hey, there's an opportunity we think we can fill out there?
Scott Kleinman
executiveYes, yes. No, this was definitely a homegrown idea that grew legs and for a lot of reasons. I mean this is really our direct origination -- larger-cap, direct origination platform. It really came out of the fact that we were actually a senior management sitting around thinking about all of the companies we touch and all of the ways we bring solution capital to companies and recognizing that not every situation, not every company can just sort of go-to-market and hit the syndicated market. Or maybe they can, but they'd rather have a more bespoke financing that needs -- may not be exactly what the market wants, but it's -- they can trade x for y and have a more relevant financing for them. Apollo had gotten to a scale -- between the relationships we have plus the scale that we are, we started to realize we don't have to be reliant on the traditional bank model of make a commitment and then go out and syndicate it and hope you end up with nothing left at the end. Our own balance sheets, between our insurance balance sheets, between our client balance sheets, between our fund balance sheets, we actually have demand to speak to these transactions and not have to worry about is this exactly what the market wants at this moment. We can do something that's much more bespoke and attractive for a particular company, and that's what -- so that put the business together, then we had to sort of test the water to see would investors be interested in a product like that. And clearly, when you explain it that way, it makes a ton of sense. And so we thankfully have had a lot of investor interest. And so it's -- we're really excited about this. We've started down the path of doing some of these directly originated transactions, and they were kind of exactly the way I described.
Jeremy Campbell
analystAnd just as a quick update for you, we're now at 20% overweight. So I don't know if new people are registering their votes now or you just sold a lot of Apollo stock in the past 2 minutes in that.
Scott Kleinman
executiveWell, keep it coming. Keep it coming.
Jeremy Campbell
analystAll right. So I guess I wanted to spend some time on private equity since we have you with us, Scott, as well. So just maybe some background on how the PE business has performed through the recent market volatility. Did it create new opportunities to invest? Or was kind of the recovery a bit too fast for you guys to be really able to capitalize on the dislocation in a meaningful way?
Scott Kleinman
executiveSure. Sure. So you asked 2 things there. Like, how is the business doing? And then where is the opportunity set? So I'll kind of try to hit each of those. Look, the business has -- our existing portfolio has sort of held up really quite well. In Q1, right when the virus hit and the lockdown hit, our portfolio marked the way I think a lot of the market moved. We did take a mark-to-market down. In Q2, we saw a pretty substantial recovery there, and while we haven't reported Q3 yet, I think you'll see an additional meaningful step-up as well in the portfolio. And that's really a function of the fact that, fortunately, the way we approach investing is a more value-oriented event. And so we had paid just generally lower prices for our portfolio and, therefore, had less absolute TEV risk on our portfolio. We also -- that means we put less leverage on the companies. And so we had less problem investments. And then perhaps most importantly, call it smart, call it fortuitous, but at the current time, we didn't have a particularly COVID-exposed portfolio. And so that's not to say we didn't have any companies that were impacted by this. We -- on prior calls, we've talked about a few. But for the most part, we had a pretty defensive portfolio that has carried through the real volatility in pretty good shape. And so all told, for the existing portfolio, we feel really good about where we are. As far as the business opportunity, yes, I would say it's sort of twofold. I'd say the first month of the crisis, it was '08, '09 over again. You had markets in free fall, really, fear in the market, a real opportunity to deploy capital in some very -- if you were prepared, which thankfully we were to deploy capital in a pretty interesting way, consistent with other downturns. This go-around though, the Fed acted a lot quicker than it did in '08, '09. What took 8 or 9 months in the GFC took 4 weeks -- 3 to 4 weeks in this crisis, as everybody knows. And so that -- a lot of the low-hanging fruit dried up very, very quickly. That's not to say there wasn't still and isn't still a lot of opportunity out there, either companies that might have grabbed some temporary liquidity but are still struggling and will continue to or even just other situations that -- where companies haven't revalued back to precrisis levels. And so I'd say it's a pretty interesting time. Yes. I mean, from an investing standpoint, the cycle -- the deep cycle was quick, but it favored the prepared.
Jeremy Campbell
analystGreat. And then as you kind of look from here and looking at the different sectors in the market, I mean, which ones are looking kind of attractive to you? And then also maybe, what would it take to get some comfort level around some of the more COVID-impacted sectors like events and things like that? We tend to think of you guys as a value manager. So maybe a kind of look at the opportunities within that one would be great.
Scott Kleinman
executiveYes, yes. So look, to maybe answer the first part of that question about sectors, right, you've clearly got some -- the last week notwithstanding, you've got some sectors that are definitely very fully valued. I mean you can just pull apart the S&P 500 and see what I'm saying, right? The 5 FAANG stocks are up, what is it, 30% from pre-COVID levels. The other 495 (sic) [ 395 ] stocks are down, what, 7% or 8%. The bottom 100 in that S&P 500 are down 40%. So huge dispersion in the markets now that doesn't follow a strict sector by sector pattern. You have leaders and laggards in most sectors. And that's really where Apollo is spending time. We're really looking for those companies that have either been misjudged by the market or misunderstood where there is opportunity. As far as the sectors that are in the direct line of fire from a COVID standpoint, look, you're right, we haven't shied away from them, where we believe that there's fundamental staying power through the other side. Think travel and leisure, aircraft, airlines, aerospace, those things. People are going to fly again. People are going to travel again. The real key, though, is if you're a value investor, I'm not prepared to predict when. Is it first quarter, second quarter? No. Actually, the way we're looking at it, we want to make sure that if it takes until 2023 or 2024 to reach pre-COVID levels, we're making an adequate return. And so that's how we've approached these type of directly COVID-hit situations. I think there's some sector -- some COVID sectors that are just -- all COVID did was accelerate an underlying trend already, some retail subsegments, for example, where it's not -- COVID didn't make it worse. It just brought the endgame a lot closer. And so those are ones, obviously, you have to be much more careful about.
Jeremy Campbell
analystAnd then I guess, within the way you guys approach the market, obviously, in the public markets, there's been a massive trend toward growth-momentum-type stocks and sectors. You kind of even see that some of your peers have extended their PE business into higher-growth areas like life sciences, technology, among others. So when you kind of look at the lens with a growth value dynamic going on, does that change how you think about approaching the market? Or do you think we're just kind of into the more of elongated kind of momentum trade at the moment?
Scott Kleinman
executiveLook, it's a fair question. And several years ago, we really started asking ourselves that, so way pre COVID. And look, I think you've started to see Apollo even, I'd say, inch -- others would say inch. I'd say step -- into growthier areas. Apollo is never going to be on the bleeding edge of growth or technology investing. But certainly, with -- in our PE fund, we've been inching towards some growthier investments. Certainly, some of our other products, our credit business, our Hybrid Value business has been financing much more growth-oriented companies, and we've been sort of developing views around that. And then lastly, I'd say, look, we are going to have a few products coming out. I can't sort of specifically say what, but in the relatively near term that start to address, like I said, that sort of next step of growth. I wouldn't say the, like you said, the life science or the sort of bleeding edge technology side but certainly growthier aspects than what Apollo traditionally had focused on.
Jeremy Campbell
analystWell, I mean even within your current book, right, we've seen your ADT and Rackspace getting interest partnerships from big tech firms like Google and Amazon. So I mean, as you look forward, is there kind of a confluence here around what you're buying and maybe augmenting a growth stock even if you're not in it?
Scott Kleinman
executiveYes. No, look, that's a great point. While we are value investors on the buy, part of what we do is buy these good, quality companies at value prices but then implement a lot of growth and a lot of things to really try to drive -- change the trajectory of those companies and seek to get better exit valuations than when we entered. A great way to do that is some of the examples you just threw out there. The -- I'm not going to speak to any specific company, but it does make sense. We're buying these, really, blue chip companies with great customer bases, great reach, great products. Technology companies have other great products, but what they really need is that reach into the customer, into the home, into things like that. And it really has proven to be a great marriage when you start putting some of these together. So I think you'll see -- we have a lot of these types of dialogues going on. I'm sure we're not the only ones doing it, and I think you'll see more and more of that.
Jeremy Campbell
analystGreat. And then I think when you think about the alt for the group, and I think you guys have spoken to this in the past call and other areas like that. I think, many times, you've talked about how this market environment right now is a little bit difficult for monetization, maybe not as much today as it was a couple of months ago but still a little tricky. I guess, what are you seeing on that front? Can you give us any update? And has there really been any improvements in the private area as we've seen kind of a recovery in the public market area?
Scott Kleinman
executiveYes. Well, look, you're right. We pointed out earlier this year once sort of COVID hit that folks should assume a pushout of the monetization curve, especially for Fund VIII. I think given the last couple of months and the strength in the market, you are starting to see opportunities to bring that forward. But the general stance that we had highlighted, whatever it was last quarter, still holds, which is '21 and '22 -- particularly if the trends continue, '21 and '22 are going to be the years where we really seek to heavily monetize Fund VIII, and that will -- I think that still stands. You may pull a little bit of that forward later this year, but it's -- I wouldn't count on it much.
Jeremy Campbell
analystGot it. And then maybe if we just broaden this discussion out a little bit more. I know like on the credit side of the business, and I know -- and Jim runs that piece of it. But can you -- in your seat right now, can you provide like some perspective about what opportunity Apollo see in credit? And then now you guys got like $15 billion of dry powder in credit, and which obviously drives a lot of meaningful management fees for the firm, what's kind of keeping you guys in the sidelines in that area right now?
Scott Kleinman
executiveYes. So look, I think the biggest single opportunity for us is what we were touching on earlier, which is the direct origination strategy. I really think the sky is the limit there. As we start to scale up, we're going to do it in a thoughtful, measured way. But I really do believe we've got a pretty unique engine here to be able to just do a fantastic job with that. I still think some of our dislocation products on the credit side are going to be periodically active. I don't believe we're really out of the woods yet. And there will be pockets of extreme volatility. And there will be periods where the market starts to realize that some of the growth or return to normal expectations for lots of companies aren't what people have been modeling at this point in time. And so that will create some interesting dislocation for our credit funds as well. To your question about capital on the sidelines, right? I mean it's a funny concept, right, because our job is to opportunistically seek out interesting situations and then have the capital available to take advantage of them when they arise and not have to go run around and try to raise the money to do it. And so for us, it's always about keeping capital in our wallet so that we don't come to a situation empty-handed. And so I think it'll always -- it's not so much that, that money's sidelined. I think the money is getting deployed. It's -- the money is getting deployed, and we continue to reload in other products. I mean that's our job. And part of what we've learned at the scale we are is that when you can come in and speak for much larger checks, you create these differentiated opportunities that others just can't take advantage of, others can't can hit, and that allows you to really skew the risk, return in your favor. So ensuring that we have some pretty sizable dollars available to go when we need it is part and parcel of our business line, and I don't think that should ever change. In fact, if you see that changing, that's when you start to worry.
Jeremy Campbell
analystAnd Martin, let's get you some work here, bud. So Scott has really kind of robustly outlined all this interesting stuff from a top line perspective. We talked about the insurance opportunity as well. We got a lot of management fee growth kind of locked and loaded. Just maybe a quick one. How should investors that are listening into this webcast kind of think about margin on a go-forward basis?
Martin Kelly
executiveYes. So we've spent a lot of time over the last 3 to 5 years on growing our margin from 20s up to mid-50s. And we're really pleased with that margin level. It's always a balance between investing in future growth, and that brings the P&L cost today. The revenues come 2, 3, 4, 5 years later. And so we're comfortable where we are given the growth opportunities we see in front of us. And so every year, we go through a very extensive 5-year planning cycle, strategy sessions and annual budget. And we debate all this. But I wouldn't expect to see much expansion in the near term as we see opportunities to further grow the platform, to address all the opportunities that Scott spoke about, to grow origination platforms and so on. And over time, I think there's potential. And at times, you get a step-change in management fees with a [ big fee ] franchise fund. That would be a time for growth. But at our current level, we're best-in-class in the industry. It's hard to argue that mid-50s is not a good place to be from a margin perspective. And so that's where I expect we'd be for the foreseeable future.
Jeremy Campbell
analystI think a lot of people would be envious of that mid-50s margin. I guess just to finish the conversation up and wrap up today. On our end, we're still doing a lot of teach-ins, one-on-ones around alts as well as [ power ] in particular. I know with C-corp conversion, index and eligibility, you're bringing a lot of newer investors to the table that might be listening to you guys the first time on a webcast like this. So I just want to give you an opportunity to address those that are -- might be newer to the story. If you had to kind of leave them with kind of one takeaway or a couple of takeaways of what you want them to understand about Apollo's business and how you distinguish yourself versus peers, I think that would be a good way to wrap up.
Scott Kleinman
executiveGreat. Thanks, Jeremy. Why don't I hit a few and then maybe, Martin, you can hit a couple as well. Look, the ones that come to my mind, I'd say, first off, it wouldn't be an Apollo presentation if we didn't spend a second talking about our integrated platform. The integrated platform really means that all of our businesses, credit, real assets, private equity, all sit on the same side of the Chinese wall. That is really unique for the large alternative asset managers. And it sounds sort of nice on paper. It's really tricky to execute in the real world. But having really gone that way over the last 30 years and then actively support it every day, it creates enormous opportunity. We've got 500 investment professionals across all these asset businesses that are really working for each other. When I look at the $80 billion of capital that Apollo has deployed in the last couple of quarters, particularly in like a post-COVID world, so many of those situations arose in one part of the firm and then were handed off. It turns out, came into a credit relationship but was a better equity deal than a credit deal or vice versa. The expertise carried over. So hugely valuable. We're really the only ones who really make the effort to make this integrated platform work. I think secondly would be scale, right, the scale from an asset gathering standpoint. LPs, investors really are looking to consolidate their relationships. And the biggest guys continue to gather more and more dollars at an accelerating pace. And that's just the nature of the situation where we are. And so I don't see anything that's going to change that. And really an important piece, being one of the largest managers, it's absolutely critical. And then, I guess, lastly, I'd just throw out our permanent capital platform. Today, over 50% -- I think it's approaching 60% -- of our capital comes from these permanent capital vehicles, these relationships. And that's just a very unique feature that is incredibly valuable. It's valuable to Apollo in that we don't have to be constantly fundraising for that half of the capital base. It allows us to make strategic, longer-term decisions around getting into really interesting, attractive businesses. I don't know, Martin. Anything else to add?
Martin Kelly
executiveYes. I mean -- 2 other things. Related to permanent capital, we have the largest credit business -- alt credit business. It's $300 billion of assets. That just -- that's a broad, deep business that just brings a lot of opportunities with it, and we continue to see a lot of areas to grow it. And I think the combination of permanent capital and stability of capital creates a durable fee stream. We had a really significant sell-off in the first quarter into the second quarter. And our management fee stream held up. It was up through that period. We've had healthy transaction fees. So I think we've shown that we can continue to grow even in really adverse market conditions. And that reflects a lot of the comments that Scott's made today, but we have a really robust FRE earnings profile and that -- and it's growing. And so I think that anchors, in our view, the stock price and creates a lot of value as an investment.
Jeremy Campbell
analystGreat. Well, Scott and Martin, I speak for everyone tuned in saying thank you very much for being here today.
Scott Kleinman
executiveGreat. Our pleasure.
Martin Kelly
executivePleasure.
Jeremy Campbell
analystThank you. Bye.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Apollo Global Management, Inc. transcript — plus 251,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Apollo Global Management, Inc. earnings transcripts and 251,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.